Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. [PDF]
Puig N +36 more
europepmc +1 more source
[Lessons learned from the evaluation of the Third Addiction Prevention Plan of Navarre]. [PDF]
Baigorria Feltrin FN +3 more
europepmc +1 more source
LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis). [PDF]
Mateos MV +22 more
europepmc +1 more source
[Effects of a personalised, adapted computerised cognitive stimulation programme versus stimulating leisure activities in younger and older adults with mild or subjective cognitive impairment. Protocol for a randomised controlled trial]. [PDF]
Gómez-Soria I +5 more
europepmc +1 more source
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance. [PDF]
Mateos MV +30 more
europepmc +1 more source

